Trial
NCT04113187
Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Bordeaux
Collaborators
AMRO-HHT-France - Association Maladie de Rendu-Osler
Condition
Hereditary Hemorrhagic Telangiectasia
Intervention
Propranolol treatment
Why stopped
target number of subject not reached
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23